{"id":339513,"date":"2026-11-04T17:00:05","date_gmt":"2026-11-04T11:30:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-q2-results-fy27-pat-192-crore\/"},"modified":"2026-11-04T17:00:05","modified_gmt":"2026-11-04T11:30:05","slug":"dr-lal-pathlabs-q2-results-fy27-pat-192-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-q2-results-fy27-pat-192-crore\/","title":{"rendered":"Dr. Lal Pathlabs Q2 Results FY27: PAT Jumps 27.62% to Rs 192.20 Cr, Revenue Rs 873.90 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Dr. Lal Pathlabs Q2 Results FY27 were declared on 4 November 2026, and the quarterly results show revenue of Rs 873.90 Cr, up 19.61% from Rs 730.60 Cr in the same quarter last year. Net profit rose to Rs 192.20 Cr from Rs 150.60 Cr, a YoY growth of 27.62%. Both lines advanced together, which the sections below break down.<\/p>\n<\/div>\n

Dr. Lal Pathlabs Ltd<\/a> (LALPATHLAB) Q2 Results FY27 announced on 4 November 2026, covering the company’s financial performance for the July to September quarter. Revenue reached Rs 873.90 Cr and PAT reached Rs 192.20 Cr, against Rs 730.60 Cr and Rs 150.60 Cr a year earlier. With the results date set as 4 November 2026, Dr. Lal Pathlabs Q2 Results FY27 record growth in both lines.<\/p>\n

This results analysis from Univest walks through the financial highlights, business drivers, outlook and risks behind Dr. Lal Pathlabs Q2 Results, keeping attention on the company’s own revenue and net profit. The Financial Highlights table follows next.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n